Oncology News

Statins used in the general population conferred a 20% risk reduction for colorectal cancer with a possibly larger impact in patients with inflammatory bowel disease, according to an analysis presented during ACG 2020 Virtual.

The mean age of patients with colorectal cancer has dropped in recent years, with a higher proportion of patients aged 40 to 50 years, according to research presented at the American College of Gastroenterology Virtual Annual Scientific Meeting.

Congratulations to all our winners!

Black patients with colorectal liver metastases had a lower likelihood of undergoing chemotherapy or resection and shorter survival than their counterparts of other races and ethnicities, according to a research letter in JAMA Network Open.

During this year’s ACG 2020 Virtual meeting, Healio will host its annual Disruptive Innovators Award ceremony on Monday, October 26.

The FDA granted orphan drug designation to APX005M for the treatment of three gastrointestinal cancer types, according to the agent’s manufacturer.

About 12% of elective colonoscopies during a recent 5-year period led to out-of-network claims that averaged hundreds of dollars more than the typical insurance payment, data in Annals of Internal Medicine show.

Positive results from a phase 2 study of a three-drug regimen to treat biliary tract cancer paved the way for the first randomized phase 3 study of its kind in the U.S., led by Rachna Shroff, MD, MS.

Pamela Kunz, MD, is an expert in GI cancers and a courageous voice against gender discrimination and harassment in health care. In this episode, Kunz shares her story and provides guidance for those facing these types of challenges.

Screen delays due to SARS-C0V-2 would significantly increase advanced colorectal cancer cases and mortality if lasting beyond 12 months, according to results presented at UEG Week Virtual Press Briefing.